EUVIMEDEUVIMED entdecken
Open Access

Csx28 is a membrane pore that enhances CRISPR-Cas13b–dependent antiphage defense

Arica R VanderWal iD, Jung-Un Park iD, Bogdan Polevoda iD, Julia K Nicosia, Adrian M Molina Vargas iD, Elizabeth H Kellogg iD, Mitchell R O'Connell iD

Science · 2023

DOI: 10.1126/science.abm1184 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science, 2023. Verfasst von Arica R VanderWal und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Biophysics, School of Medicine and Dentistry, University of Rochester, Rochester, NY, USA. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, RNA, Viral, Bacterial Proteins, Endodeoxyribonucleases. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NIH HHS, NIDCR NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type VI CRISPR-Cas systems use RNA-guided ribonuclease (RNase) Cas13 to defend bacteria against viruses, and some of these systems encode putative membrane proteins that have unclear roles in Cas13-mediated defense. We show that Csx28, of type VI-B2 systems, is a transmembrane protein that assists to slow cellular metabolism upon viral infection, increasing antiviral defense. High-resolution cryo–electron microscopy reveals that Csx28 forms an octameric pore-like structure. These Csx28 pores localize to the inner membrane in vivo. Csx28’s antiviral activity in vivo requires sequence-specific cleavage of viral messenger RNAs by Cas13b, which subsequently results in membrane depolarization, slowed metabolism, and inhibition of sustained viral infection. Our work suggests a mechanism by which Csx28 acts as a downstream, Cas13b-dependent effector protein that uses membrane perturbation as an antiviral defense strategy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CRISPR-Cas SystemsRNA, ViralBacterial ProteinsEndodeoxyribonucleasesCRISPR-Associated ProteinsRNA CleavageBacteriophagesPrevotellaCryoelectron MicroscopyMembrane ProteinsBacteriophage lambdaEscherichia coli

Substanzen

Membrane ProteinsRNA, ViralBacterial ProteinsEndodeoxyribonucleasesCRISPR-Associated Proteins

Autor:innen und Institutionen

  • Department of Biochemistry and Biophysics, School of Medicine and Dentistry, University of Rochester, Rochester, NY, USA.
  • Center for RNA Biology, University of Rochester, Rochester, NY, USA.
  • Department of Molecular Biology and Genetics, Cornell University, Ithaca, NY, USA.

ORCID-Profile: Arica R VanderWal, Jung-Un Park, Bogdan Polevoda, Adrian M Molina Vargas, Elizabeth H Kellogg, Mitchell R O'Connell

Förderung

  • NIGMS NIH HHS
  • NIH HHS
  • NIDCR NIH HHS

Zitieren

APA

VanderWal, A. R., Park, J. U., Polevoda, B., Nicosia, J. K., Molina Vargas, A. M., Kellogg, E. H., & O'Connell, M. R. (2023). Csx28 is a membrane pore that enhances CRISPR-Cas13b–dependent antiphage defense. Science. https://doi.org/10.1126/science.abm1184

Vancouver

VanderWal AR, Park JU, Polevoda B, Nicosia JK, Molina Vargas AM, Kellogg EH, et al. Csx28 is a membrane pore that enhances CRISPR-Cas13b–dependent antiphage defense. Science. 2023. doi:10.1126/science.abm1184

BibTeX
@article{VanderWal2023,
  author = {VanderWal, Arica R and Park, Jung-Un and Polevoda, Bogdan and Nicosia, Julia K and Molina Vargas, Adrian M and Kellogg, Elizabeth H and O'Connell, Mitchell R},
  title = {Csx28 is a membrane pore that enhances CRISPR-Cas13b–dependent antiphage defense},
  journal = {Science},
  year = {2023},
  doi = {10.1126/science.abm1184}
}
Kostenlos starten →